Clinic
Planned Parenthood Los Angeles Pomona Center
Planned Parenthood Los Angeles Pomona Center was paid $7.31M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is J3490, Unclassified drugs — 12% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD LOS ANGELES POMONA CENTER
POMONA, CA 91767
POMONA, CA 91767
33aNPI1710076997assigned 10/12/2006
33bProvider typeCommunity Health Clinic/Center
28Total paid$7.31M
24GClaims182,772
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in California
Rank by total paid#47 of 288
Median peer was paid$2.15M
This provider vs. median3.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,639 | $1.92M | |
| 2019 | 29,318 | $1.17M | |
| 2020 | 21,651 | $717K | |
| 2021 | 23,914 | $1.01M | |
| 2022 | 20,073 | $651K | |
| 2023 | 25,836 | $966K | |
| 2024incomplete | 22,341 | $877K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J3490 | Unclassified drugs | 12% | 23,693 | 19,574 | $846K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 11% | 864 | 861 | $800K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.9% | 5,503 | 5,133 | $647K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8.4% | 11,242 | 10,584 | $615K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.9% | 6,742 | 6,446 | $579K |
| S4993 | Contraceptive pills for birth control | 7.1% | 6,083 | 6,053 | $523K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 6.5% | 2,678 | 2,640 | $475K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.3% | 1,482 | 1,430 | $462K |
| 87806 | 4.3% | 12,792 | 10,390 | $314K | |
| 99201 | 3.7% | 2,416 | 2,296 | $268K | |
| 11981 | 2.7% | 810 | 810 | $196K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.6% | 987 | 934 | $189K |
36 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.5% | 8,256 | $186K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.3% | 8,258 | $170K |
| A4267 | Contraceptive supply, condom, male, each | 2.1% | 23,282 | $152K |
| 58300 | 1.9% | 1,278 | $136K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 1.2% | 300 | $90K |
| J7300 | Intrauterine copper contraceptive (paragard) | 1.0% | 113 | $76K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 1.0% | 5,957 | $76K |
| 11976 | <1% | 1,041 | $67K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 178 | $66K |
| 99401 | <1% | 3,225 | $61K | |
| 81025 | <1% | 17,819 | $56K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 444 | $34K |
| 99000 | <1% | 9,308 | $32K | |
| S5000 | Prescription drug, generic | <1% | 4,279 | $31K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | <1% | 60 | $27K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 29 | $22K |
| 83986 | <1% | 6,699 | $18K | |
| 86703 | <1% | 1,603 | $17K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 2,447 | $15K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 3,669 | $13K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 662 | $10K |
| S0190 | Mifepristone, oral, 200 mg | <1% | 159 | $9K |
| 86592 | <1% | 3,104 | $8K | |
| 58301 | <1% | 251 | $7K | |
| 81002 | <1% | 1,817 | $3K | |
| 82120 | <1% | 973 | $3K | |
| 87210 | <1% | 995 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 356 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 12 | $894.85 |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 233 | $623.37 |
| 86901 | <1% | 203 | $465.08 | |
| 99402 | <1% | 12 | $381.48 | |
| 85018 | <1% | 187 | $359.29 | |
| 99070 | <1% | 231 | $213.38 | |
| 99072 | <1% | 28 | $0.02 | |
| 36416 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPAHL, LINDA (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.